| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 163443 | Null | 0.0396077140933377 | 0.1413321 |
| NSC 173552 | L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate | 0.0396077140933377 | 0.25276933 |
| NSC 244404 | Null | 0.0396077140933377 | 0.3513192 |
| NSC 3077 | s-Triazine, 4,6-diamino-1-(3,4-dichlorophenyl)-1,2-dihydro-2,2-dimethyl-, monohydrochloride (8CI) | 0.0396077140933377 | -0.11058535 |
| NSC 30915 | Null | 0.0396077140933377 | 0.64637393 |
| NSC 351521 | Ethanesulfonic acid, 2-hydroxy-, compd. with 6-[(2,5-dimethoxyphenyl)methyl]-5-methylpyrido[2,3-d] pyrimidine-2,4-diamine (1:1) | 0.0396077140933377 | 0.3294568 |
| NSC 39215 | Null | 0.0396077140933377 | 0.56590627 |
| NSC 601518 | Null | 0.0396077140933377 | 0.68902958 |
| NSC 614887 | Platinum, (1,2-cyclohexanediamine-N,N')bis (4-morpholinepropanesulfonato-O)-, (SP-4-2) | 0.0396077140933377 | 0.57503513 |
| NSC 624657 | ANTINEOPLASTIC-624657 | 0.0396077140933377 | 0.37888765 |